Jpmorgan Chase & CO Caribou Biosciences, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 433,359 shares of CRBU stock, worth $875,385. This represents 0.0% of its overall portfolio holdings.

Number of Shares

433,359

Previous 464,027 6.61%

Holding current value

$875,385

Previous $761,000 11.04%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$1.56 - $2.73 $47,842 - $83,723	-30,668 Reduced 6.61%	433,359 $845,000
Q2 2024 Aug 12, 2024	SELL	$1.62 - $5.05 $137,742 - $429,381	-85,026 Reduced 15.49%	464,027 $761,000
Q1 2024 May 10, 2024	SELL	$4.82 - $8.26 $134,627 - $230,710	-27,931 Reduced 4.84%	549,053 $2.82 Million
Q4 2023 Feb 12, 2024	BUY	$3.58 - $6.25 $16,489 - $28,787	4,606 Added 0.8%	576,984 $3.31 Million
Q3 2023 Nov 14, 2023	SELL	$4.08 - $8.14 $80,800 - $161,204	-19,804 Reduced 3.34%	572,378 $2.74 Million
Q2 2023 Aug 11, 2023	SELL	$4.04 - $5.47 $43,615 - $59,054	-10,796 Reduced 1.79%	592,182 $2.52 Million
Q1 2023 May 18, 2023	BUY	$4.3 - $7.78 $184,758 - $334,283	42,967 Added 7.67%	602,978 $3.2 Million
Q1 2023 May 11, 2023	SELL	$4.3 - $7.78 $172,369 - $311,869	-40,086 Reduced 6.68%	560,011 $2.97 Million
Q4 2022 Feb 13, 2023	SELL	$5.57 - $11.01 $6,979 - $13,795	-1,253 Reduced 0.21%	600,097 $3.77 Million
Q3 2022 Nov 14, 2022	BUY	$5.34 - $12.79 $490,115 - $1.17 Million	91,782 Added 18.01%	601,350 $6.34 Million
Q2 2022 Aug 11, 2022	SELL	$5.1 - $9.74 $31,568 - $60,290	-6,190 Reduced 1.2%	509,568 $2.77 Million
Q1 2022 May 11, 2022	BUY	$8.42 - $15.32 $4.19 Million - $7.62 Million	497,692 Added 2754.85%	515,758 $4.74 Million
Q4 2021 Feb 10, 2022	BUY	$14.59 - $23.26 $160,519 - $255,906	11,002 Added 155.75%	18,066 $273,000
Q3 2021 Nov 12, 2021	BUY	$15.75 - $30.29 $111,258 - $213,968	7,064 New	7,064 $169,000

Others Institutions Holding CRBU

# of Institutions

135

Shares Held

52.6M

Call Options Held

148K

Put Options Held

70.7K

View Full List

About Caribou Biosciences, Inc.

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $123M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

More about CRBU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Caribou Biosciences, Inc. Transaction History